Stay updated on Oral Immunotherapy for Peanut Allergic Patients Clinical Trial
Sign up to get notified when there's something new on the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page.

Latest updates to the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page
- Check7 days agoChange DetectedThe record describes a recruiting Phase I/II trial of oral INP20 immunotherapy for peanut-allergic patients, including its treatment arms, eligibility criteria, study locations, and safety and efficacy measures. It also provides the study’s contacts, investigators, and record dates.SummaryDifference45%

- Check14 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice announces NIH's transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study record page now returns a 403 Forbidden error instead of displaying the trial details. This replaces the previous content with an access-denied notice, preventing users from viewing the study information.SummaryDifference18%

Stay in the know with updates to Oral Immunotherapy for Peanut Allergic Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Immunotherapy for Peanut Allergic Patients Clinical Trial page.